Location History:
- Aichi-gun, JP (2011)
- Gifu, JP (1995 - 2012)
- Aichi, JP (2011 - 2012)
Company Filing History:
Years Active: 1995-2012
Title: **Innovative Contributions of Nobuo Sugiura**
Introduction
Nobuo Sugiura is an accomplished inventor based in Gifu, Japan, known for his significant contributions to the fields of biochemistry and polymer science. With a total of 10 patents to his name, Sugiura has made remarkable advancements, particularly in the development of chondroitin polymerases and their applications in the production of sugar chain fractions.
Latest Patents
Among Sugiura's latest patents is the innovative "Chondroitin polymerase and DNA encoding the same." This patent describes a chondroitin polymerase that alternately transfers GlcUA and GalNAc to a non-reduced terminal of a sugar chain, detailing the process for producing this enzyme. Another significant patent is the "Process for preparation of chondroitin fraction," which outlines a method for creating a fraction with over 50% of chondroitin represented by a specific formula. This process is designed to enable industrial-scale production of chondroitin fractions with controlled saccharide content ratios through a cost-effective and simplified procedure.
Career Highlights
Throughout his career, Nobuo Sugiura has been associated with prominent companies such as Seikagaku Corporation and Seikagaku Kogyo Kabushiki Kaisha. His work within these organizations has further advanced the understanding of chondroitin compounds and their beneficial applications in various industries.
Collaborations
Sugiura has collaborated with notable colleagues, including Koji Kimata and Sakaru Suzuki. These partnerships have enabled fruitful exchanges of ideas and expertise, driving further innovations in their respective fields.
Conclusion
Nobuo Sugiura's work lays a foundation for future innovations in biochemistry and polymer applications. His patents not only showcase his inventive spirit but also contribute significantly to the advancement of science and technology. As he continues to explore the intricacies of chondroitin and related compounds, the impact of his inventions is likely to resonate across multiple sectors.